Literature DB >> 16547413

Epithelial cells secrete interleukin-8 in response to adhesion and invasion of diffusely adhering Escherichia coli lacking Afa/Dr genes.

Ismail Mustafa Meraz1, Kentaro Arikawa, Jun Ogasawara, Atsushi Hase, Yoshikazu Nishikawa.   

Abstract

Escherichia coli that sparsely adhere to human epithelial cells are known as diffusely adherent E. coli (DAEC), and the role of the Afa/Dr family of adhesins is now understood. Strains that do not possess Afa/Dr, however, comprise another group of DAEC, of which the pathogenicity remains unknown. The ability to induce interleukin-8 (IL-8) secretion from intestinal epithelial cells might be a feature of enterovirulent bacteria. We previously found that some Afa/Dr DAEC strains induce IL-8 by stimulating epithelial cells with flagella. The present study examines whether non-Afa/Dr DAEC can induce IL-8 in epithelial cells (HEp-2, INT407, and T84). Among 21 strains, 11 (52%; 11/21) induced as much IL-8 as high inducer strains of Afa/Dr DAEC. Adhesion did not significantly differ between high and low inducers; therefore diffuse adhesion alone is probably insufficient to induce IL-8. It was shown that IL-8 induction and the number of intracellular bacteria directly correlated. Wortmannin, an inhibitor of the phosphatidylinositol-3-phosphate kinase, reduced both intracellular bacteria and IL-8 secretion. Motile strains were significantly more prevalent among high (10/11) than low (4/10) inducers. However, 4 low invasive strains hardly induced IL-8 despite their motility. In conclusion, some non-Afa/Dr DAEC invoke the induction of high levels of inflammatory cytokines. Unlike Afa/Dr DAEC, however, non-Afa/Dr strains may require invasion to cause strong induction. These non-Afa/Dr high inducers can be enteropathogenic for the cytokine-inducing properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547413     DOI: 10.1111/j.1348-0421.2006.tb03781.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

Review 1.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

2.  Diffusely Adherent Escherichia coli Strains Isolated from Healthy Carriers Suppress Cytokine Secretions of Epithelial Cells Stimulated by Inflammatory Substances.

Authors:  Yoshihiko Tanimoto; Sayaka Tamai; Takehiro Matsuzaki; Narumi Takeuchi; Takumi Noju; Saki Yanagida; Eriko Kage-Nakadai; Yoshihiro Yamaguchi; Toshio Kodama; Shota Nakamura; Daisuke Motooka; Tetsuya Iida; Yoshikazu Nishikawa
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

Review 3.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico.

Authors:  Jamal A Mohamed; Herbert L DuPont; Zhi-Dong Jiang; Jose Flores; Lily G Carlin; Jaime Belkind-Gerson; Francisco G Martinez-Sandoval; Dongchuan Guo; A Clinton White; Pablo C Okhuysen
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

5.  BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability.

Authors:  Yash A Choksi; Vishruth K Reddy; Kshipra Singh; Caitlyn W Barrett; Sarah P Short; Bobak Parang; Cody E Keating; Joshua J Thompson; Thomas G Verriere; Rachel E Brown; M Blanca Piazuelo; David M Bader; M Kay Washington; Mukul K Mittal; Thomas Brand; Alain P Gobert; Lori A Coburn; Keith T Wilson; Christopher S Williams
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.